Eggshell membrane in the treatment of pain and stiffness from osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled clinical study

Kevin J Ruff, Anne Winkler, Robert W Jackson, Dale P DeVore, Barry W Ritz, Kevin J Ruff, Anne Winkler, Robert W Jackson, Dale P DeVore, Barry W Ritz

Abstract

Natural Eggshell Membrane (NEM(R)) is a new novel dietary supplement that contains naturally occurring glycosaminoglycans and proteins essential for maintaining healthy articular cartilage and the surrounding synovium. The randomized, multicenter, double-blind, placebo-controlled Osteoarthritis Pain Treatment Incorporating NEM(R) clinical study was conducted to evaluate the efficacy and safety of NEM(R) as a treatment for pain and stiffness associated with osteoarthritis of the knee. Sixty-seven patients were randomly assigned to receive either oral NEM(R) 500 mg (n = 34) or placebo (n = 33) daily for 8 weeks. The primary endpoint was the change in overall Western Ontario and McMasters Universities (WOMAC) Osteoarthritis Index as well as pain, stiffness, and function WOMAC subscales measured at 10, 30, and 60 days. The clinical assessment was performed on the intent-to-treat population. Supplementation with NEM(R) produced an absolute rate of response that was statistically significant (up to 26.6%) versus placebo at all time points for both pain and stiffness, but was not significantly improved for function and overall WOMAC scores, although trending toward improvement. Rapid responses were seen for mean pain subscores (15.9% reduction, P = 0.036) and mean stiffness subscores (12.8% reduction, P = 0.024) occurring after only 10 days of supplementation. There were no serious adverse events reported during the study and the treatment was reported to be well tolerated by study participants. Natural Eggshell Membrane (NEM(R)) is an effective and safe option for the treatment of pain and stiffness associated with knee osteoarthritis. Supplementation with NEM(R), 500 mg taken once daily, significantly reduced both joint pain and stiffness compared to placebo at 10, 30, and 60 days.

Trial registration: ClinicalTrials.gov NCT00750477.

Figures

Fig. 1
Fig. 1
Enrollment, randomization, and completion flow diagram

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/art.23176', 'is_inner': False, 'url': 'https://doi.org/10.1002/art.23176'}, {'type': 'PMC', 'value': 'PMC3266664', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc3266664/'}, {'type': 'PubMed', 'value': '18163497', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/18163497/'}]}
    2. Lawrence RC, Felson DT, Helmick CG et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58(1):26–35
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/archinte.163.2.169', 'is_inner': False, 'url': 'https://doi.org/10.1001/archinte.163.2.169'}, {'type': 'PubMed', 'value': '12546607', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12546607/'}]}
    2. Case JP, Baliunas AJ, Block JA (2003) Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis. Arch Intern Med 163:169–178
    1. Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G (2006) Acetaminophen for osteoarthritis. Cochrane Database of Systematic Reviews, No. 2
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.287.1.64', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.287.1.64'}, {'type': 'PubMed', 'value': '11754710', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/11754710/'}]}
    2. Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ (2002) Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee. J Am Med Assoc 287(1):64–71
    1. None
    2. Altman RD (1999) Ibuprofen, acetaminophen and placebo in osteoarthritis of the knee: a six-day double-blind study [abstract]. Arthritis Rheum 42:S403
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa050493', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa050493'}, {'type': 'PubMed', 'value': '15713943', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15713943/'}]}
    2. Bresalier RS, Sandler RS, Quan H et al (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092–1102
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa050405', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa050405'}, {'type': 'PubMed', 'value': '15713944', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15713944/'}]}
    2. Solomon SD, McMurray JJ, Pfeffer MA et al (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352:1071–1080
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa050330', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa050330'}, {'type': 'PubMed', 'value': '15713945', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15713945/'}]}
    2. Nussmeier NA, Whelton AA, Brown MT et al (2005) Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352:1081–1091
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1186/ar2047', 'is_inner': False, 'url': 'https://doi.org/10.1186/ar2047'}, {'type': 'PMC', 'value': 'PMC1779447', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc1779447/'}, {'type': 'PubMed', 'value': '16995929', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16995929/'}]}
    2. Singh G, Wu O, Langhorne P, Madhok R (2006) Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Res Ther 8(5):153–162
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1136/bmj.325.7365.619', 'is_inner': False, 'url': 'https://doi.org/10.1136/bmj.325.7365.619'}, {'type': 'PMC', 'value': 'PMC126301', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc126301/'}, {'type': 'PubMed', 'value': '12242171', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12242171/'}]}
    2. Deeks JD, Smith LA, Bradley MD (2002) Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. Br Med J 325:619–627
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8803564', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/8803564/'}]}
    2. Laine L (1996) Nonsteroidal anti-inflammatory drug gastropathy. Gastrointest Endosc Clin N Am 6(3):489–504
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa052771', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa052771'}, {'type': 'PubMed', 'value': '16495392', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16495392/'}]}
    2. Clegg DO, Reda DJ, Harris CL et al (2006) Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354(8):795–808
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/art.22371', 'is_inner': False, 'url': 'https://doi.org/10.1002/art.22371'}, {'type': 'PubMed', 'value': '17265490', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/17265490/'}]}
    2. Herrero-Beaumont G, Ivorra JAR, Trabado MC et al (2007) Glucosamine sulfate in the treatment of knee osteoarthritis symptoms. Arthritis Rheum 56(2):555–567
    1. U.N. Food & Agriculture Organization: FAO Statistical Yearbook—United States of America (2004)
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/0012-1606(84)90033-2', 'is_inner': False, 'url': 'https://doi.org/10.1016/0012-1606(84)90033-2'}, {'type': 'PubMed', 'value': '6203793', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/6203793/'}]}
    2. Wong M, Hendrix MJC, von der Mark K et al (1984) Collagen in the egg shell membranes of the hen. Devel Biol 104(1):28–36
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1243460', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc1243460/'}, {'type': 'PubMed', 'value': '13864145', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/13864145/'}]}
    2. Baker JR, Balch DA (1962) A study of the organic material of hen's-egg shell. Biochem J 82:352–361
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '4750752', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/4750752/'}]}
    2. Picard J, Paul-Gardais A, Vedel M (1973) Sulfated glycoproteins from egg shell membranes and hen oviduct. Isolation and characterization of sulfated glycopeptides. Biochimica et Biophysica Acta 320:427–441
    1. Long FD, Adams RG, and DeVore DP (September 20, 2005) Preparation of hyaluronic acid from eggshell membrane. USA Patent #6946551
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12705414', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12705414/'}]}
    2. Nakano T, Ikawa NI, Ozimek L (2003) Chemical composition of chicken eggshell and shell membranes. Poult Sci 82:510–514
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.3109/03008208009152122', 'is_inner': False, 'url': 'https://doi.org/10.3109/03008208009152122'}, {'type': 'PubMed', 'value': '6450664', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/6450664/'}]}
    2. Starcher BC, King GS (1980) The presence of desmosine and isodesmosine in eggshell membrane protein. Connect Tissue Res 8:53–55
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.3109/03008200109016840', 'is_inner': False, 'url': 'https://doi.org/10.3109/03008200109016840'}, {'type': 'PubMed', 'value': '11913770', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/11913770/'}]}
    2. Gautron J, Hincke MT, Panheleux M et al (2001) Ovotransferrin is a matrix protein of the hen eggshell membranes and basal calcified layer. Conn Tissue Res 42:255–267
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10556569', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/10556569/'}]}
    2. Akagawa M, Wako Y, Suyama K (1999) The presence of desmosine and isodesmosine in eggshell membrane protein. Biochim Biophys Acta 14:151–160
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0945-053X(00)00095-0', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0945-053x(00)00095-0'}, {'type': 'PubMed', 'value': '10980420', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/10980420/'}]}
    2. Hincke MT, Gautron J, Panheleux M et al (2000) Identification and localization of lysozyme as a component of eggshell membranes and eggshell matrix. Matrix Biol 19:443–453
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/art.1780350502', 'is_inner': False, 'url': 'https://doi.org/10.1002/art.1780350502'}, {'type': 'PubMed', 'value': '1575785', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/1575785/'}]}
    2. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498–502
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '3068365', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/3068365/'}]}
    2. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.joca.2004.02.001', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.joca.2004.02.001'}, {'type': 'PubMed', 'value': '15094138', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15094138/'}]}
    2. Pham T, van der Heijde D, Altman RD et al (2004) OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 12:389–399
    1. Systat Software, Inc. , San Jose, CA, USA:
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1136/bmj.330.7492.672-b', 'is_inner': False, 'url': 'https://doi.org/10.1136/bmj.330.7492.672-b'}, {'type': 'PMC', 'value': 'PMC554954', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc554954/'}, {'type': 'PubMed', 'value': '15775007', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15775007/'}]}
    2. Tubach F, Ravaud P, Giraudeau B (2005) Managing osteoarthritis of the knee: conclusions about use of NSAIDs are misleading. Br Med J 330:672
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.ejpain.2006.09.001', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.ejpain.2006.09.001'}, {'type': 'PubMed', 'value': '17067835', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/17067835/'}]}
    2. McQuay H, Moore A (2007) Utility of clinical trial results for clinical practice. Eur J Pain 11:123–124
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1186/ar2394', 'is_inner': False, 'url': 'https://doi.org/10.1186/ar2394'}, {'type': 'PMC', 'value': 'PMC2453757', 'is_inner': False, 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2453757/'}, {'type': 'PubMed', 'value': '18384679', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/18384679/'}]}
    2. Moore RA, Moore OA, Derry S, McQuay HJ (2008) Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores. Arthritis Res Ther 10(2):5
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.pain.2006.01.010', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.pain.2006.01.010'}, {'type': 'PubMed', 'value': '16472919', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16472919/'}]}
    2. Lötsch J, Geisslinger G (2006) Current evidence for a genetic modulation of the response to analgesics. Pain 121:1–5
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/archneur.61.7.1066', 'is_inner': False, 'url': 'https://doi.org/10.1001/archneur.61.7.1066'}, {'type': 'PubMed', 'value': '15262737', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15262737/'}]}
    2. Saver JL (2004) Number needed to treat estimates incorporating effects over the entire range of clinical outcomes. Arch Neurol 61:1066–1071
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.2146/ajhp040558', 'is_inner': False, 'url': 'https://doi.org/10.2146/ajhp040558'}, {'type': 'PubMed', 'value': '16174840', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16174840/'}]}
    2. Wen L, Badgett R, Cornell J (2005) Number needed to treat: a descriptor for weighing therapeutic options. Am J Health Syst Pharm 62(19):2031–2036
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1080/03009740701607067', 'is_inner': False, 'url': 'https://doi.org/10.1080/03009740701607067'}, {'type': 'PubMed', 'value': '18092260', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/18092260/'}]}
    2. Kristensen LE, Christensen R, Bliddal H, Geborek P, Danneskiold-Samsøe B, Saxne T (2007) The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review. Scand J Rheumatol 36:411–417

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera